{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:31:24Z","timestamp":1781195484314,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0837-2.12\/17"],"award-info":[{"award-number":["APQ-0837-2.12\/17"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgar.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:16:42Z","timestamp":1587964602000},"page":"511-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, blaNDM-1 and blaKPC-2"],"prefix":"10.1016","volume":"22","author":[{"given":"Elza Ferreira","family":"Firmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Bel\u00e9m","family":"Oliveira J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexsandra Maria Lima","family":"Scavuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Andr\u00e9","family":"Brayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyana Leal","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catarina de Souza","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.04.014_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jgar.2019.08.026","article-title":"Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzyme genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil","volume":"21","author":"Firmo","year":"2019","journal-title":"J Global Antimicrob Resist"},{"key":"10.1016\/j.jgar.2020.04.014_bib0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1590\/1414-431x20144154","article-title":"Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates","volume":"48","author":"Quiles","year":"2015","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jgar.2020.04.014_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkr431","article-title":"Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India","volume":"67","author":"Kumarasamy","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14656566.2015.993381","article-title":"Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials","volume":"16","author":"Thabit","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01815-17","article-title":"Evaluation of activity and emergence of resistance of polymyxin B and ZTI-01 (fosfomycin for injection) against KPC-producing Klebsiella pneumoniae","volume":"62","author":"Diep","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/mdr.2018.0397","article-title":"In vitro effectiveness of meropenem and cefmetazole combination treatment against KPC-2-producing Enterobacteriaceae","volume":"25","author":"Hagiya","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2020.04.014_bib0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.diagmicrobio.2018.10.020","article-title":"Killing activity of meropenem in combination with amikacin against VIM- or KPC-producing Enterobacteriaceae that are susceptible, intermediate, or resistant to amikacin","volume":"93","author":"Kulengowski","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.014_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00540-17","article-title":"Polymyxin combinations combat Escherichia coli harboring mcr-1 and blaNDM-5: preparation for a postantibiotic era","volume":"8","author":"Bulman","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2020.04.014_bib0045","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/AAC.00741-13","article-title":"Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time\u2013kill experiments","volume":"58","author":"Tangden","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0050","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018"},{"key":"10.1016\/j.jgar.2020.04.014_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0060","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"1999"},{"key":"10.1016\/j.jgar.2020.04.014_bib0065","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/AAC.03639-14","article-title":"In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae","volume":"59","author":"Lim","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0070","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/AAC.00270-16","article-title":"In vitro activity of polymyxin B in combination with various antibiotics against extensively drug-resistant Enterobacter cloacae with decreased susceptibility to polymyxin B","volume":"60","author":"Cai","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.014_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.diagmicrobio.2018.11.011","article-title":"Synergy of polymyxin B, tigecycline and meropenem against carbapenem-resistant Enterobacter cloacae complex isolates","volume":"94","author":"Alves","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.014_bib0080","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ja.2017.73","article-title":"Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae","volume":"70","author":"Kulengowski","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jgar.2020.04.014_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/17425255.2019.1563071","article-title":"Novel \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens","volume":"15","author":"Karaiskos","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jgar.2020.04.014_bib0090","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/jac\/dkw213","article-title":"Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24h in vitro time\u2013kill experiments","volume":"71","author":"Lagerb\u00e4ck","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:02:03Z","timestamp":1761991323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":18,"alternative-id":["S2213716520301065"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.04.014","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, blaNDM-1 and blaKPC-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}